Erlotinib Hydrochloride Tablet, Film Coated
Product Images NDC 46708-565

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Erlotinib Hydrochloride (NDC 46708-565). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Alembic Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

30 Tablets (Erlotinib 100)

Each film-coated tablet contains 100mg of erlotinib free base. The usual dosage is available in the enclosed package insert. The tablets should be stored at 25°C with excursions permitted to 15° to 30°C. The package is child-resistant. The manufacturer is Alembic Pharmaceuticals Limited located in Gujarat, India. The product is Erlotinib Tablets with NDC number 46708-566-30. The remaining text is not decipherable.*

FDA Label Image

30 Tablets (Erlotinib 150)

Each tablet contains 150mg of erlotinib free base. Please see the enclosed package insert for complete prescribing information including the usual dosage. The package is child-resistant and must be stored at a temperature between 15°C to 30°C. Manufactured by Alembic Pharmaceuticals in Gujarat, India, the package contains 30 tablets of Erlotinib. The lot number and expiry date are not available.*

FDA Label Image

30 Tablets (Erlotinib 25)

Each film-coated tablet of Erlotinib contains 25mg of erlotinib free base. See enclosed package insert for dosage and complete prescribing information. The tablets should be stored at 25°C (77°F), with excursions permitted between 15° to 30°C (59° to 86°F) as guided by USP Controlled Room Temperature. The manufacturer of Erlotinib tablets is Alembic Pharmaceuticals Limited, located at Survey No. 84, 87 and 88, Panelav, Taluka Halol, Panchmahal, Gujarat 389350, India. The tablets are available in a pack of 30, with a National Drug Code (NDC) of 46708-565-30 labeled with "Rxonly." The Lot number and EXP date are not available.*

FDA Label Image

Figure1 (Erlotinib Figure1)

FDA Label Image

Figure 2 (Erlotinib Figure2)

FDA Label Image

Figure 3 (Erlotinib Figure3)

This appears to be a partial table with survival probabilities and number of patients at risk for two treatments (placebo and erlotinib) and different time periods. The table provides information on overall survival in months for the two treatments.*

FDA Label Image

Figure4 (Erlotinib Figure4)

FDA Label Image

Structure (Erlotinib Str2)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.